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Abstract
Objective: Controlled inpatient studies on the effects of food, physical activity (PA), and insulin dosing on glucose excursions
exist, but such outpatient data are limited. We report here outpatient data on glucose excursions and its key determinants
over 5 days in 30 adolescents with type 1 diabetes (T1D) as a proof-of-principle pilot study.
Subjects and Methods: Subjects (20 on insulin pumps, 10 receiving multiple daily injections; 15 – 2 years old; diabetes
duration, 8 – 4 years; hemoglobin A1c, 8.1 – 1.0%) wore a continuous glucose monitor (CGM) and an accelerometer for 5 days.
Subjects continued their existing insulin regimens, and time-stamped insulin dosing data were obtained from insulin pump
downloads or insulin pen digital logs. Time-stamped cell phone photographs of food pre- and post-consumption and food
logs were used to augment 24-h dietary recalls for Days 1 and 3. These variables were incorporated into regression models to
predict glucose excursions at 1–4 h post-breakfast.
Results: CGM data on both Days 1 and 3 were obtained in 57 of the possible 60 subject-days with an average of 125 daily
CGM readings (out of a possible 144). PA and dietary recall data were obtained in 100% and 93% of subjects on Day 1 and
90% and 100% of subjects on Day 3, respectively. All of these variables influenced glucose excursions at 1–4 h after waking,
and 56 of the 60 subject-days contributed to the modeling analysis.
Conclusions: Outpatient high-resolution time-stamped data on the main inputs of glucose variability in adolescents with T1D
are feasible and can be modeled. Future applications include using these data for in silico modeling and for monitoring
outpatient iterations of closed-loop studies, as well as to improve clinical advice regarding insulin dosing to match diet and
PA behaviors.
Introduction
The importance of dietary intake and physical activity(PA) on glucose excursions for the care of type 1 diabetes
(T1D) is well accepted,1–3 yet these key human behaviors are
poorly integrated into current decision-making regarding
insulin dosing. At best, insulin dosing is given as a function of
total carbohydrate (CHO), combined with ‘‘rules of thumb’’
based on clinical consensus and individual experience plus
consideration for anticipated PA.4
Numerous carefully controlled inpatient studies have been
performed to establish the interrelationship of glucose ex-
cursions with insulin dose timing,5,6 type of bolus delivery,7
diet,5,8,9 and PA.10 These studies and others have provided
important data on the effects of these variables on glucose
excursions for the treatment of T1D; however, as with any
inpatient study, the translation of these data to the outpatient
environment is uncertain.
Given advances in technology, we posited that such data
could be obtained in an outpatient setting, capturing the real-
life experiences of youth. We used current technologies to
concurrently measure factors that determine glucose ex-
cursions by use of the following time-stamped data: (1) the
outcome variable glucose excursions obtained with contin-
uous glucose monitoring (CGM); (2) insulin dosing obtained
via insulin pump or insulin pen with a digital log; (3) dietary
intake obtained with diet records and 24-h dietary recall and
confirmed with digital camera phone technology; and (4)
PA obtained via accelerometry, plus self-report integrated
with the 24-h dietary recall process. Herein, we present
these integrated pilot data obtained in an outpatient setting
in adolescents and establish a proof-of-principle that such
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high-resolution data acquisition is possible and can be
used in regression models to predict outpatient glucose
excursions.
Research Design and Methods
The study population were adolescents seen at the Barbara
Davis Center for Childhood Diabetes 12–18 years old with
T1D for > 1 year who were using insulin/CHO ratios and
using either insulin pump therapy (Medtronic [Northridge,
CA] or Animas [West Chester, PA]) or on multiple daily in-
jections (MDI). Subjects with celiac disease, T1D with < 1 year
in duration, hemoglobin A1c (HbA1c) > 12%, or not on an
insulin pump or using MDI insulin therapy were excluded.
The study was approved by the Colorado Multiple Institu-
tional Review Board, and all participants provided informed
assent or consent (if ‡ 18 years).
Study visits
Basic demographics, clinical and anthropometric data, and
medical history were collected along with nutrition education
received (amount, type) and CHO counting practices (when
subjects CHO count, what resources are used, insulin bolus-
ing behavior, etc.). A standard questionnaire based on those
used in the SEARCH for Diabetes in Youth study11 was ad-
ministered by study staff and used to obtain past medical and
family history, demographics such as date of birth and eth-
nicity, insulin dosing, and CHO counting questions. Height,
weight, and blood pressure were measured using standard
methods,11 and body mass index was calculated. HbA1c
values were obtained from the patient’s most recent clinic visit
(DCA Vantage analyzer, Siemens Healthcare Diagnostics,
Tarrytown, NY).
The FreeStyle Navigator (Abbott Diabetes Care,
Alameda, CA) CGM system was inserted, and subjects were
instructed on its use. Subjects were shown how to wear the
Actical accelerometer (Phillips Respironics, Bend, OR) and
when it was acceptable to remove the device (sleeping and
bathing). Instructions on how to fill out the food and PA re-
cords (on Days 1 and 3) were reviewed. As part of the initial
study visit, subjects were asked about their usual insulin/
CHO ratio and the modifications to the ratio for exercise or
glucose levels that are made regularly. On days assigned for
diet record keeping, subjects were asked to record times of
meals, snacks, and PA. The timing of insulin boluses was
captured in either the insulin pump download or the Lilly
(Indianapolis, IN) Memoir pen digital log.
Participants filled out food and activity records (at home)
for Days 1 and 3 during the 5-day study period, and these
records were transmitted electronically for use on the fol-
lowing day to facilitate administration of a 24-h dietary and
PA recall, which took place on Day 2 (regarding Day 1) and
Day 4 (regarding Day 3). Recalls were conducted by phone
by trained staff at the University of North Carolina Diet
Assessment, Body Composition and Physical Activity Core
of the National Institute of Diabetes and Digestive and
Kidney Diseases–funded Nutrition Obesity Research Center.
The participant then returned on Day 5 to have the CGM
device removed and downloaded along with the insulin
pump or Lilly Memoir pen data, cell phone, and accelero-
meter. Specific details of data acquisition for each variable
follow.
Data acquisition and analysis—outcome: glucose
excursion data
CGM was performed using the FreeStyle Navigator
system, which provided a glucose reading every 10 min for a
5-day period. Subjects were blinded to the data.12 The primary
outcome variable was glucose data from the CGM system, but
glucose meter data were obtained and required to calibrate
the CGM device.
Predictors of glucose excursions
Insulin dosing data. Data from the insulin pump or the
Lilly Memoir pen, which included time of bolus deliver, were
compiled at the completion of the 5-day CGM period. If
subjects were using the Lilly Memoir pen, then they were
instructed to go through the digital memory on the pen daily
and record date, time, and units of insulin given on a log given
to them at the initial study visit. This log was faxed/scanned
to the study coordinator along with the food and activity logs
on Days 2 and 4. The pen’s memory was also reviewed by
study staff on Day 5. Data on insulin/CHO ratios used, basal
insulin rates (glargine or detemir), and correction factors for
hyperglycemia were recorded. In addition, logs were pro-
vided for the study participants to record comments on any
decisions to override bolusing decisions based on insulin/
CHO ratio or on correction factor boluses that commonly
occur due to impending exercise or other factors. Adjustment
of insulin for impending exercise is currently a formidable
challenge for closed-loop technology in an outpatient setting,
and we used these forms to capture insulin dosing adjust-
ments made for exercise or other factors.
Dietary data. Diet was assessed using an integration of
standardized food records, camera cell phone-based time-
stamped pictures of food to be consumed and after con-
sumption, and detailed 24-h dietary recalls for Days 1 and 3.
Traditional food records were done on Days 1 and 3. The food
logs were supplemented by use of camera cell phone pictures.
In addition to providing the time-stamp, a standard measure
(e.g., a ruler or coin) was used to provide an embedded scale
to facilitate portion size estimation, as we have done previ-
ously and used by numerous studies.13–18 Finally, using the
food logs and photos to prompt the subject, nutritionists at the
University of North Carolina administered a detailed 24-h
dietary recall using standardized methods supported by
Nutrition Data System for Research. Specifically, the day
following each day of recorded intake, a nutritionist reviewed
the food record with the subject following the rigorous pro-
tocol of a multiple-pass 24-h dietary recall, with particular
attention to estimation of portion size, review of possible
omissions to the record, and review of timing of meals and
snacks. The method of combined use of food records and 24-h
dietary recalls has recently been shown to provide good
validity compared with directly observed dietary intake in
youth.19
PA data. Two complementary methodologies were used
to obtain data on PA. First, PA was collected from the PDPAR,
which is an interviewer-administered PA record. Second,
each subject wore an Actical accelerometer that provided
time-stamped data on each subjects’ activity. Accelerometers
provided data on physical exertion in real time. This approach
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provides both the activities of the adolescents (PDPAR) and
an objective (accelerometry) measure of exercise intensity.
Both instruments provided information on the pattern of ac-
tivity, which allowed for the evaluation of timing of activity
with respect to meals, insulin, and glucose excursions. The
PDPAR divides the day into half-hour time blocks and re-
quires the respondent to report the dominant activity and
the approximate intensity of that activity for that period,
categorized as ‘‘light,’’ ‘‘medium,’’ ‘‘hard,’’ or ‘‘very hard.’’
The PDPAR was administered in the same session as the 24-h
dietary recall. The interview was used to cue the previous
day’s activities and to determine what activities these ado-
lescents were performing.
The Actical has been validated against continuous mea-
surements of energy expenditure in a respiratory room calo-
rimeter and measurements in an exercise laboratory using a
portable calorimeter and treadmill in 7–18-year-old chil-
dren.20 The Actical also compared favorably with total energy
expenditure measured from the doubly labeled water method
in 10 normal-weight premenopausal women over 14 days,
and the Actical21 better estimated total energy expenditure
compared with the ActiGraph (Pensacola, FL) device by
more than 12%. Accelerometer data were recorded in 15-s
epochs, and four consecutive records were added to get an
activity count per minute. Participants were instructed to
wear the accelerometer continuously and remove it only for
sleeping and bathing. Participants also recorded activity in
the same 30-min blocks queried in the PDPAR. The objectively
time-stamped accelerometry data were used in statistical
modeling of the predictors of glucose excursions, and the
PDPAR data were used in interpretation of findings relative to
the actual activities in which the youth engaged. When ana-
lyzing the accelerometry data we excluded periods of > 1 h
with no activity right before midnight and sleep time, which is
defined as having > 2 h with no activity and less than 10 min
awake between midnight and 6 a.m. (0600 h). Activity below
10 counts/min was considered as no activity. To determine
minutes at various PA levels the 15-s epoch were converted
to minute epochs by adding four nearby epochs. Then the
following classifications of accelerometry data were made:
sedentary, £ 50 counts/min; light, 51–2,000 counts/min;
moderate, 2,001–2,900 counts/min; and vigorous, > 2,900
counts/min.22
Statistical methods
Descriptive baseline data are stratified by pump/MDI
status of the subjects; no statistical tests were performed as
there were no a priori hypotheses tested based on insulin
delivery modality, but rather subjects using both types of
insulin delivery were included to demonstrate feasibility of
data acquisition. Mean ( – SD) CGM, physical activity, and
dietary data on Days 1 and 3 were computed. The following
indices were calculated using CGM data: mean – SD of daily
recordings, number of daily glucose recordings, and per-
centage of time spent < 70 mg/dL, 70–180 mg/dL, 180–
300 mg/dL, and > 300 mg/dL.23,24 Only Day 1 and Day 3 data
were used in the analysis because, by design, those were the
days in which complete nutrition data (24-h recall) were
performed.
Linear regression models were performed using an auto-
regression and moving average correlation matrix to account
for within-person correlation to predict CGM between 1 h
before and 4 h after the first meal of the day. This type of
analysis allowed us to use all complete days of data, even
though some data (e.g., either insulin, glucose, PA, or diet)
were missing from some subjects for either day. Other corre-
lation matrices were considered, but the autoregression and
moving average had the smallest (best) Akaike criterion in-
dex. The following time varying variables were considered as
predictors of CGM: time (per 10-min increments), square term
of time, first CGM reading (1 h prior to first meal), body
weight, daily basal insulin and cumulative bolus insulin, cu-
mulative PA, and cumulative CHO and fiber intake. PROC
MIXED in SAS version 9.2 (SAS Institute, Cary, NC) was used
for the regression analysis.
Results
Participant characteristics stratified by insulin regimen
(pump or MDI) are shown in Table 1 and overall had the
following characteristics: 63% male, 90% non-Hispanic white,
15.2 – 2.0 years old, diabetes duration 7.3 – 4.5 years, body
mass index z-score 0.3 – 0.8, and HbA1c 8.1 – 1.0%. Both
groups had similar total daily doses of insulin and distribu-
tion as basal/bolus, but those on pumps had more daily bo-
luses (6.2 – 2.9 vs. 2.9 – 1.3).
Descriptive data on CGM by day are listed in Table 2 Data
were similar by pump and MDI, on Days 1 and 3, and when
examined in those in whom greater than 75% compared with
less than 75% of CGM recordings were obtained (data not
shown). CGM data on both Days 1 and 3 were obtained in 57
of the possible 60 subject-days with an average of 125 daily
CGM readings (out of a possible 144), with a mean glucose of
200 – 68 mg/dL. Among these readings 3% were < 70 mg/dL,
48% were between 70 and 180 mg/dL, 32% were between 181
and 300 mg/dL, and 17% were > 300 mg/dL. Results were
very similar in the subset of 46 days in which ‡ 75% of CGM
recordings were obtained on both Days 1 and 3.
Descriptive data on non-sleep accelerometer data are dis-
played in Table 2 by day, with 100% of subjects with data on
Day 1 and 90% on Day 3 (14–16 h/day of accelerometry data).
Activity during non-sleep averaged 200 – 139 counts/minute.
Subjects spent approximately 2% of their time (15–20 min/
day) in moderate or vigorous activity and 28–31% (approxi-
mately 4.5 h/day) in light activity, with 67–70% ( > 10 h/day)
of their time during these 2 days being sedentary.
Results of the 24-h dietary recall are given in Table 2 for
Days 1 and 3 (97% and 100% complete, respectively). Subjects
averaged 2,353 kcal in 7 – 3 meals and snacks daily. Forty-
seven percent of calories were from CHOs, 17% from protein,
and 37% from fat, and dietary fiber intake was 18 – 9 g/day.
One example of the temporal effects of insulin (basal and
bolus), CHO intake, and PA on glucose excursions as mea-
sured by CGM is depicted in Figure 1. The following points
were evident: (1) multiple boluses of insulin given 1–2 h prior
to, (2) vigorous exercise with, (3) resultant hypoglycemia,
cessation of exercise, and (4) ingestion of excess CHO with
subsequent rebound hyperglycemia.
Regression analyses predicting CGM at 1, 2, 3, and 4 h after
the first meal of the day are presented in Table 3. Of the 60
subject-days, 56 had data that contributed to these analyses.
As expected, the first CGM value significantly predicted CGM
at 1, 2, 3, and 4 h. Among dietary data, cumulative CHO
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(increased) and fiber (decreased) significantly predicted
CGM. For PA, cumulative light PA significantly predicted
increased CGM at all time points, and moderate-to-vigorous
PA (which was recorded only approximately 1% of the time)
significantly predicted decreased CGM at 1 and 2 h and pre-
dicted decreased CGM at 3 and 4 h. Cumulative basal insulin
was not a significant predictor of CGM, but cumulative bolus
significantly predicted decreased CGM at all time points.
Conclusions
In this study we demonstrate the feasibility of obtaining
high-resolution time-stamped data on the main inputs of
glucose variability in adolescents with T1D in an outpatient
setting. Previous studies have performed such detailed data
collection in an inpatient setting to carefully control research
variables, but also due to previous technological limitations.
We found adolescents willing and able to follow this research
protocol to gather these data for a 5-day study period, and
these methods present opportunities for future research and
clinical care.
These data are consistent with previous studies in adoles-
cents with T1D that report suboptimal glucose control,25 poor
dietary habits,26 and limited PA.27,28 For example, the mean
HbA1c was 8.1 – 1.0%, above the target of 7.5%, with only 48%
of time spent in relative euglcyemia of 70–180 mg/dL. Ad-
ditionally, as is not uncommon in adolescents, subjects re-
ported 7 – 3 meals or snacks daily (but only 6.2 [pump] or 2.9
[MDI] boluses daily), with 37% of calories as fat and only
18 – 9 g of fiber daily. Finally, subjects spent only 1% of their
day (17 min) in moderate-to-vigorous PA and 19% (4.5 hours)
in light PA.
These data highlight the current challenges to achieving
tight glucose control in adolescents with T1D. For example, if
seven meals or snacks are consumed daily then optimally this
requires seven insulin boluses (either via pump or injection) to
Table 2. Continuous Glucose Monitoring,
Physical Activity, and Nutritional Intake
Day 1 Day 3
CGM
Number of patients 30 27
CGM average (mg/dL) 195 (57) 205 (80)
Number of daily recordings 124 (29) 126 (31)
% < 70 mg/dL 3.5 (5.7) 3.1 (5.4)
% 70–180 mg/dL 50.9 (25.5) 44.5 (27.2)
% 181–300 mg/dL 30.8 (18.8) 34.0 (20.0)
% > 300 mg/dL 14.8 (19.9) 18.5 (26.2)
Physical activity (n)a 30 27
Non-sleep mean
(counts/min)
213 (151) 186 (127)
Sedentary (min/day) 592 (41.1%) 632 (43.9%)
Light (min/day) 278 (19.3%) 259 (18.0%)
Moderate (min/day) 11 (0.7%) 9 (0.6%)
Vigorous (min/day) 9 (0.6%) 6 (0.4%)
Nutritional intake
Days with diet recall 29 30
Number of meals
and snacks/day
7 (3) 8 (3)
Total energy (Kcal) 2,187 (1,101) 2,513 (1,028)
Total CHO (g) 263 (113) 294 (150)
Dietary fiber (g) 17 (7) 20 (10)
Data are mean (SD) values. The SD was not adjusted for within-
person correlation. Pump and MDI subjects were combined.
aSleeping time is defined as having > 2 h with no activity and less
than 10 min woken up, or > 1 h no activity right before midnight.
Sedentary is defined as not sleeping and £ 50 counts/min, light
activity as 51–2,000 counts/min, moderate as 2,001–2,900 counts/min,
and vigorous as > 2,900 counts/min, measured as accelerometer
counts.
CGM, continuous glucose monitoring; CHO, carbohydrate.
Table 1. Participant Characteristics
Mean percentage or (SD) [range]a




Hispanic/Asian Indian 10.0% 10.0%
Age (years) 15.1 (1.8) [12–18] 15.4 (2.3) [12–18]
Weight (kg) 64.8 (16.8) [41.9–111] 62.4 (8.5) [52.8–75.4]
Height (cm) 172 (11.2) [151–192] 168 (12.4) [154–188]
BMI (kg/m2) 21.6 (3.8) [17.3–32.5] 22.2 (3.0) [18.4–27.3]
BMI z-scoreb 0.3 (0.9) [ - 1.4 to 2.1] 0.4 (0.6) [ - 0.5 to 1.2]
T1DM duration (years) 7.8 (4.4) [1.7–14.8] 6.2 (4.5) [1.1–15.5]
HbA1c (%) 8.0 (0.8) [6.9–10.1] 8.3 (1.3) [6.0–10.1]
Daily insulin (Days 1 and 3)
Total units (basal + bolus)/day 57.5 (25.1) [18.6–146] 59.9 (32.9) [20.0–180]
Basal (units) 26.8 (13.5) [7.5–87.0] 30.0 (12.9) [11.0–60.0]
Bolus (units) 30.2 (16.0) [3.4–71.4] 29.2 (22.5) [3.0–120]
Number of boluses/day 6.2 (2.9) [1.0–17.0] 2.9 (1.3) [1.0–6.0]
% basal 48.9% 53.0%
% bolus 51.1% 47.0%
aSD not adjusted for within-person correlation for insulin doses.
bUsing 2000 Centers for Disease Control and Prevention growth charts.
BMI, body mass index; HbA1c, hemoglobin A1c; MDI, multiple daily injections; T1DM, type 1 diabetes mellitus.
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limit glucose excursions. These data are consistent with pre-
vious studies showing missed boluses for meals29 or snacks30
are common in adolescents and associated with poorer glu-
cose control. Given the current onset of action of rapid-acting
insulin analogs, it is desirable to give boluses up to 20 min
prior to eating, depending on blood glucose at that time,
which adds another layer of complexity to diabetes care.5
Similarly, the prolonged duration of action (approximately 4 h)
of rapid-acting insulin results in persistent effects of insu-
lin on glycemia that may overlap with PA and result in
FIG. 1. Example of temporal relationship of insulin doses, carbohydrate (CHO), and physical activity (PA) with continuous
glucose monitoring (CGM): region 1, multiple boluses for hyperglycemia; region 2, vigorous PA; region 3, hypoglycemia with CHO
treatment and cessation of PA; and region 4, rebound hyperglycemia. Color images available online at www.liebertonline.com/dia
Table 3. Regression Models to Predict Continuous Glucose Monitoring
Between 1 and 4 H After the First Meal
Estimate (95% CI)
Variable 1 h 2 h 3 h 4 h
Intercept 50.4 ( - 2.5, 103.2) 55.6 ( - 14.6, 125.9) 40.6 ( - 65.3, 146.5) 56.3 ( - 50.8, 163.5)
Time (10-min) 3.77 (2.86, 4.68)a 1.93 (0.70, 3.15)a 1.34 (0.07, 2.61)a 1.29 (0.11, 2.47)a
(Time)2 0.65 (0.44, 0.87)a 0.11 ( - 0.04, 0.27) - 0.02 ( - 0.11, 0.07) - 0.08 ( - 0.14, - 0.01)a
First CGM (mg/dL) 0.79 (0.72, 0.85)a 0.82 (0.74, 0.91)a 0.90 (0.82, 0.99)a 0.74 (0.67, 0.82)a
Cumulative
CHO (g) 0.27 (0.16, 0.39)a 0.41 (0.28, 0.55)a 0.28 (0.16, 0.40)a 0.24 (0.14, 0.33)a
Fiber (g) - 4.02 ( - 5.73, - 2.30)a - 6.51 ( - 8.63, - 4.38)a - 2.53 ( - 4.35, - 0.70)a - 2.41 ( - 3.80, - 1.02)a
Bolus (U) - 1.17 ( - 1.58, - 0.75)a - 1.71 ( - 2.24, - 1.18)a - 1.92 ( - 2.40, - 1.44)a - 1.27 ( - 1.65, - 0.90)a
PA (min)
Light 1.00 (0.72, 1.28)a 0.71 (0.44, 0.97)a 0.88 (0.68, 1.09)a 0.87 (0.73, 1.01)a
Moderate-vigorous 1.84 (0.11, 3.56)a 4.68 (3.23, 6.12)a - 2.46 ( - 3.67, - 1.25)a - 3.36 ( - 4.11, - 2.60)a
Body weight (kg) - 0.34 ( - 1.31, 0.63) - 0.20 ( - 1.49, 1.10) - 0.88 ( - 2.81, 1.05) - 0.51 ( - 2.44, 1.42)
Daily basal (U) - 0.11 ( - 1.19, 0.97) - 0.46 ( - 1.90, 0.98) 0.98 ( - 1.02, 2.99) 0.69 ( - 1.22, 2.60)
aStatistically significant.
CGM, continuous glucose monitoring; CI, confidence interval; CHO, carbohydrate; PA, physical activity.
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hypoglycemia. Such an example is depicted in Figure 1, in
which multiple boluses were given to correct for hypergly-
cemia 1–2 h prior to vigorous exercise. Combined, these re-
sulted in hypoglycemia and cessation of exercise to overtreat
the hypoglycemia with CHO with subsequent rebound hy-
perglycemia. Unfortunately, moderate-to-vigorous PA was
rare in this cohort, and concern for hypoglycemia is one bar-
rier that can prevent or limit PA and its health benefits.31 PA-
related hyperglycemia can be a result of the effects of the
sympathetic nervous system during PA,32 a pre-activity
strategy to avoid anticipated PA-induced hypoglycemia, or a
result of overtreatment of a low blood sugar; all of these can
lead to poorer glucose control and present a challenge to
people with T1D to achieve recommended daily PA goals.
Refinement of insulin dosing algorithms for either a closed-
or hybrid-closed loop artificial pancreas or for current dia-
betes management is a topic of intensive investigation.33 To
date, data informing such efforts have been based on inpatient
studies in small groups of subjects in which variables are
carefully controlled. Outpatient data such as those we present
here could provide a complementary dataset on which to
develop such dosing decisions or a methodology by which
outpatient implementation of such insulin dosing algorithms
(either patient or device driven) could be monitored. Results
of the regression analyses show the expected associations of
insulin dosing, diet, and PA on resultant CGM values 1–4 h
post-waking. Future articles will include more detailed ana-
lyses of these associations as well as the accuracy of CHO
counting, insulin-to-CHO ratios, and the effect of diet on
glucose excursions.
Given advances in diabetes technology, it is not difficult to
envision enhanced dietary programs on future insulin pumps
via smartphones or other platforms. Similarly, accelerometry
devices could also be incorporated to enhance adjustments for
PA. Challenges will exist in precisely and accurately obtaining
such data, but perhaps even more so with processing and
translating such data into a format that is usable for both the
patient and the diabetes care team. Possible future applica-
tions using data such as those obtained in this study include
the following: (1) Can accelerometry provide a ‘‘rule’’ or ad-
vice on how to adjust insulin doses for periods of exercise and
to predict and avoid hypoglycemia post-exercise, especially
nocturnally? (2) Can real-time data for food intake be used for
insulin dosing, and if so, how can this be presented in a ‘‘user-
friendly’’ format? (3) Can these methods and data be used to
identify a pattern of inputs that can predict hypo- or hyper-
glycemia and alert patients so that preemptive actions can be
taken? (4) How does dysglycemia (either hypo- or hypergly-
cemia) predict future dysglycemia, and how might these be
avoided?
Strengths of our study include its methodologic novelty in
acquiring these time-stamped data in an outpatient setting in
adolescents for whom compliance with a detailed research
protocol can be a challenge. On the other hand, adolescents
are the population of people with T1D who typically have the
highest HbA1c but also the greatest willingness and aptitude
to adopt technology, and this offers the possibility that novel
technology could have the greatest benefit in this age group.
Subjects tolerated wearing a CGM device and accelerometer
well for this 5-day study period, although previous studies
have highlighted that improvements in such technologies must
be made to increase their use for extended period of time.34
A recent outpatient study combined CGM and accelerometry
in 16 adolescents with T1D for 3 days but did not include
dietary or insulin dosing data.35 Limitations of our study in-
clude uncertainties about generalization of these data to all
adolescents with T1D. We also did not obtain complete data on
all subjects, although this is also the case with inpatient studies
because of imperfections in applying technology to human use
(i.e., CGM failure). It is also possible that not all boluses via the
Memoir pen were recorded by the subjects, although daily
recording was performed, and the lower number of boluses in
the MDI population may be due to the increased effort to bolus
with MDI as compared with a pump. Finally, these 5 days may
not be representative of these adolescents’ typical days, but it is
our opinion that this methodology is more likely to capture
typical behavior than inpatient studies.
In conclusion, these data demonstrate the feasibility of
outpatient acquisition of high-resolution time-stamped data
on the main inputs of glucose variability in adolescents with
T1D. Future applications include using these data for in silico
modeling and for monitoring outpatient iterations of closed-
loop studies, as well as clinically to advise insulin dosing and
refine current diabetes care. Advances in diabetes technology
will continue as will the challenge to adapt these technologies
into ‘‘user-friendly’’ formats for both patients and diabetes
care teams.
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